Solvent system for chronic vascular infusion of hydrophobic drug

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514724, A61K 3700, A61K 31045

Patent

active

049435604

ABSTRACT:
The present invention provides a liquid infusate for the chronic vascular infusion of a hydrophobic biologically-active compound, such as cyclosporin, comprising a solution of a therapeutically-effective amount of the biologically-active compound in a mixture of about 10-80% glycerol and about 90-20% ethanol, by volume.

REFERENCES:
patent: 3731681 (1973-05-01), Blackshear
patent: 4108985 (1978-08-01), Ruegger et al.
patent: 4439181 (1984-03-01), Blackshear et al.
patent: 4998823 (1989-01-01), Witzel
The Merck Index, 10th Ed.(1983), p. 396, No. 2748.
Wigness et al., Chem. Abst. 105(9):85142g.
B. D. Wigness et al., Trans. Am. Soc. Artif. Inter. Organs, XXXI, 136-139, (1985).
Brange et al., Properties of Insulin in Solution, in Artificial Systems for Insulin Delivery (P. Brunetti 1983), at pp. 83-84. Lougheed et al., Diabetologia, 19, 1-9 (1980).
H. Buchwald et al., Implantable Infusion Pumps, Year Book medical Publishers, Inc., 177-221 at 185 (1984).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Solvent system for chronic vascular infusion of hydrophobic drug does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Solvent system for chronic vascular infusion of hydrophobic drug, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solvent system for chronic vascular infusion of hydrophobic drug will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1267811

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.